Research Topics
| P R EbelingSummaryAffiliation: University of Melbourne Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Bone turnover markers and bone density across the menopausal transitionP R Ebeling
Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
J Clin Endocrinol Metab 81:3366-71. 1996..In conclusion, the perimenopause is associated with elevated bone resorption rates and declining BMD, and factors in addition to estrogen deficiency may also contribute to the pathogenesis of postmenopausal osteoporosis...- Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and managementP R Ebeling
Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Victoria, Australia
Drugs Aging 13:421-34. 1998..Effective public health measures also need to be established and targeted to men at risk of developing the disease... - A prospective study of bone loss in menopausal Australian-born womenJ R Guthrie
Department of Psychiatry, Royal Melbourne Hospital, Victoria, Australia
Osteoporos Int 8:282-90. 1998..05), such that women with higher BMI had less bone loss. In conclusion, during the time of transition from peri- to post-menopause, women had accelerated BMD loss at both the hip and spine... - Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantationA P Grigg
Department of Clinical Haematology and Medical Oncology, Clinical Haematology and Bone Marrow Transplant Service, Melbourne, Victoria, Australia
Intern Med J 36:600-3. 2006..8% (range, -27.6 to +24.4%). Four patients continued to lose bone from the spine post-ZA. ZA reduces bone loss in most patients after alloHSCT. Our data require confirmation in a larger prospective, randomized study... 
A review of the clinical implications of bisphosphonates in dentistryG L Borromeo
Melbourne Dental School, The University of Melbourne, Victoria, Australia
Aust Dent J 56:2-9. 2011..In the context of substantial uncertainty, the implications of bisphosphonate use in the dental clinical setting are still being determined...- Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal studyK L Bennell
School of Physiotherapy, University of Melbourne, Australia
Bone 20:477-84. 1997..Our results provide further support for the concept that bone response to mechanical loading depends upon the bone site and the mode of exercise... - Role of biochemical markers in the management of osteoporosisP R Ebeling
Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia
Best Pract Res Clin Rheumatol 15:385-400. 2001..Thus, the transition of biochemical bone markers into everyday clinical practice may be rapidly approaching... - Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg
Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia
J Clin Endocrinol Metab 91:3835-43. 2006..Studies of more potent bisphosphonates or anabolic therapy with PTH after alloSCT are warranted with the aim of durable maintenance of bone mass... - Teriparatide (rhPTH 1-34) for the treatment of osteoporosisP R Ebeling
Department of Diabetes, The University of Melbourne, Royal Melbourne Hospital, Australia
Int J Clin Pract 57:710-8. 2003..When given by once-daily injection, teriparatide increases bone mass by stimulating formation of new bone, resulting in the restoration of bone architecture... - Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab)C Gagnon
Department of Medicine, University of Melbourne, Western Hospital, Melbourne, Australia
Osteoporos Int 21:2067-74. 2010.... - Association between knee cartilage volume and bone mineral density in older adults without osteoarthritisF Cicuttini
Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Prahran 3181, Victoria, Australia
Rheumatology (Oxford) 43:765-9. 2004..We conducted a cross-sectional study to determine the relationship between knee cartilage volume, a direct measure of joint cartilage, and bone mineral density (BMD) in an adult population... - Vitamin D deficiency in general medical inpatients in summer and winterS M Chatfield
Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Intern Med J 37:377-82. 2007..These patients often have coexistent risk factors for its consequences. This study aims to document a point prevalence of vitamin D deficiency in this population... - Vitamin D deficiency is common and unrecognized among recently arrived adult immigrants from The Horn of AfricaS A Skull
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
Intern Med J 33:47-51. 2003..Routine assessment for vitamin D deficiency should be considered for male and female immigrants from East Africa... - Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factorS J King
Nutrition Dept, Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Eur Respir J 25:54-61. 2005..In conclusion, reduced bone mineral density in cystic fibrosis is associated with a number of factors, including DeltaF508 genotype, male sex, greater lung disease severity and malnutrition... - Factors affecting knee cartilage volume in healthy menF M Cicuttini
Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Prahran 3181, Australia
Rheumatology (Oxford) 42:258-62. 2003..To understand the factors that influence joint cartilage in health and disease as they are important for the prevention and management of osteoarthritis... - Predictors of bone mineral density in aging healthy men varies by skeletal siteB L Clarke
Division of Endocrinology and Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Calcif Tissue Int 70:137-45. 2002..We conclude that predictor variables of bone density vary by skeletal site in healthy men. Alterations in adrenal androgens, phosphate, and PTH may be important in the pathogenesis of bone loss with aging in men...